February 9, 2007
Cephalon Announces Positive Results for FENTORA for Breakthrough Pain in Patients with Chronic Low Back Pain
Cephalon announced that data from a Phase 3 clinical trial of FENTORA [C-II] demonstrate efficacy in the mgmt of breakthrough pain in opioid-tolerant patients with chronic low back pain.
More: continued here















Leave a comment